Pharmaceutical company responses to Canadian opioid advertising restrictions: A framing analysis.

ABSTRACT: The pharmaceutical industry's promotion of opioids in North America has been well-documented. Yet despite the clear consequences of improperly classifying pharmaceutical company messaging and frequently permissive approaches that allow the pharmaceutical industry to self-regulate its own advertising, there has been scarce investigation to date of how pharmaceutical industry stakeholders interpret definitions of "advertising." This study explores how variations of "marketing" and "advertising" are strategically framed by the different actors involved in the manufacturing and distribution of pharmaceutical opioids. We employed a framing analysis of industry responses to Health Canada's letter to Canadian manufacturers and distributors of opioids requesting their commitment to voluntarily cea

SUBMITTER: Eisenkraft Klein D 

PROVIDER: S-EPMC10310031 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature